Navigation Links
Virginia Interventional and Vascular Associates Offers Alternative to Hysterectomy for Uterine Fibroids
Date:4/22/2009

National OB-GYN Group States Uterine Artery Embolization 'Safe and Effective' for Appropriately Selected Patients

FREDERICKSBURG, Va., April 22 /PRNewswire/ -- Women with painful uterine fibroids are more likely to opt for a minimally invasive procedure over hysterectomy in the months ahead. That's the prediction of Virginia Interventional and Vascular Associates (VIVA) doctors following a bulletin on uterine artery embolization by The American College of Obstetricians and Gynecologists.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090421/NE02051 )

"Based on long- and short-term outcomes, uterine artery embolization is a safe and effective option for appropriately selected women who wish to retain their uteri," the practice bulletin reports. The bulletin, released in 2008, also evaluates other alternatives to hysterectomy.

Dr. R. Donald Doherty Jr. of VIVA, a group of interventional radiologists in Fredericksburg, VA, says their practice has performed uterine artery embolizations since 2001. The procedure, also known as uterine fibroid embolization (UFE), is offered primarily by interventional radiologists. Interventional radiologists apply their skills in reading medical images and performing minimally invasive procedures to diagnose and treat a variety of conditions.

"We applaud the ACOG for recognizing UFE as an effective alternative," Doherty says. "Many women have suffered from fibroids and have avoided surgical treatment because they are concerned about downtime from work, loss of income and other issues. The ACOG bulletin has opened the way for women to discuss with their OB-GYNs the treatment options that are available to them."

UFE is a minimally invasive procedure that blocks the blood supply to fibroids, causing them to shrink. It usually requires an overnight hospital stay. Most women resume light activities in a few days and the majority of women return to normal activities within seven to 10 days, according to the Society of Interventional Radiology. The society estimates that 85-90 percent of UFE patients experience significant or total improvement in pain and heavy bleeding caused by fibroids.

About VIVA

VIVA is part of Radiologic Associates of Fredericksburg. Its board-certified interventional radiologists are Dr. Michael P. McDermott, Dr. John J. McLaughlin, Dr. R. Donald Doherty Jr., and Dr. John D. Statler. VIVA doctors help diagnose and treat a variety of conditions, including uterine fibroids, spinal compression fractures, peripheral vascular disease, cancer, and varicose veins. For more information, call (540) 654-9118 or visit www.imagingway.com/ufe .


'/>"/>
SOURCE Virginia Interventional and Vascular Associates
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Report Has National Importance
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. Virginia Techs Raving First Year Results Lead to Additional High-Tech Antimicrobial Defense from SportCoatings(TM)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
7. Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products
8. The Virginia G. Piper Charitable Trust and Flinn Foundation launch
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. States Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic
11. Virginia Attorney General Addresses Drunk Driving and Underage Drinking in New Radio Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: